Illumina Stock Plunges 14%, Wiping Out $6.1 Billion Despite Raised 2026 Profit Outlook
The DNA-sequencing company lifted its full-year earnings and sales forecasts, but third-quarter revenue missed analyst estimates by $20 million.
Illumina, which makes DNA-sequencing tools, plunged 13.86% to $249.86 in Friday trading, as of 9:48 a.m. ET, erasing $6.1 billion in market value a day after it raised its 2026 profit forecast. Third-quarter revenue came in below analyst estimates, and the stock had roughly doubled this year.
Beat on profit, miss on sales
Third-quarter revenue was $1.13 billion, $20 million short of analyst estimates. Adjusted earnings of $1.44 a share beat those estimates by $0.08.
The company's 8-K filed Thursday lifted the lower end of its profit range: $5.30 becomes $5.40, with the top at $5.45, before tariff refunds. Its new 2026 revenue outlook, also excluding tariff refunds, is $4.64 billion to $4.66 billion.
A stock priced for more
Illumina shares were up about 121% this year at Thursday's close, against about 13% for the S&P 500. The stock sat within 2% of its highest close of the past year, set on October 5, before Friday's session, so expectations for the report were high.
The drop was on pace to be its biggest one-day fall in at least 275 trading sessions, since Sept. 26, 2025. Investor's Business Daily attributed the slide to tariff confusion and a shaky backdrop for AI-linked tech stocks.
A slide goes away
On the earnings call, the chief financial officer said Illumina will stop showing its slide tracking customers' shift to the NovaSeq X sequencer after the fourth quarter, because that conversion is nearing completion.
The market value lost, about $6.1 billion, left Illumina near $37.7 billion at Friday's morning price.
Sources
- Illumina Stock Crashes As AI Woes Mount And Tariffs Eat Into Sales | Investor's Business Daily — investors.com
- Illumina (ILMN) Q3 Earnings Beat Estimates — Yahoo Finance
- Illumina falls despite boosting full-year profit, revenue guidance | Seeking Alpha — seekingalpha.com
- Illumina Non-GAAP EPS of $1.44 beats by $0.08, revenue of $1.13B misses by $20M (NASDAQ:ILMN) | Seeking Alpha — seekingalpha.com
- Illumina Earnings: Market Disappointed That Growth Has Not Accelerated Further — morningstar.com
- The company's filing (Illumina) — SEC filing
- Illumina — Form 10-Q for the quarter ended 2026-06-28 (quarterly results) — SEC EDGAR